1. Stocks
    2. /
  2. Mesoblast Limited (ASX: MSB)
    3. /

Mesoblast Limited (ASX: MSB) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Mesoblast Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Mesoblast Limited (ASX: MSB)
    Latest News

    The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a sour start to the trading week this session.

    Read more »

    Multi-ethnic people looking at camera sitting at public place screaming, shouting and feeling overjoyed about their windfall, good news or sports victory.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    ASX shares finally reversed their losses today.

    Read more »

    Two boys looking at each other while standing by start line on stadium against two schoolgirls.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a Garfield-esque start to the trading week.

    Read more »

    Three people in a corporate office pour over a tablet, ready to invest.
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    | James Mickleboro

    Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

    Read more »

    2 street signs with winner and loser COVID recovery oil price
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a happy end to the trading week today.

    Read more »

    Smiling man sits in front of a graph on computer while using his mobile phone.
    Broker Notes

    Leading brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's why brokers believe that now could be the time to snap up these shares.

    Read more »

    Arrows pointing upwards with a man pointing his finger at one.
    Healthcare Shares

    Why Mesoblast shares could rocket 60% higher

    | James Mickleboro

    Let's see why Bell Potter is tipping this stock as a buy right now.

    Read more »

    A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
    Share Fallers

    Why Lynas, Mesoblast, PEXA, and Sayona Mining shares are tumbling today

    | James Mickleboro

    These shares are ending the week in the red. But why?

    Read more »

    A man flies into the sky over a city building-scape with a rocket jet pack sketched onto his back representing the Imugene share price skyrocketing today
    Healthcare Shares

    A $115 million growth opportunity!? Is this ASX 200 stock about to skyrocket?

    | Samantha Menzies

    The company's share price has jumped 141.67% over the past 12 months.

    Read more »

    a person stands arms outstretched on the top of a mountain with a beautiful sunrise in the sky
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    Investors sent the ASX 200 into higher uncharted territory today.

    Read more »

    A happy investor sits at his desk in front of his laptop and does the mexican wave with his arms to celebrate the returns from his ASX dividend shares
    Record Highs

    Oops, the ASX 200 did it again! Another record high

    | Bronwyn Allen

    The ASX 200 reset its record high for the third time in a week and a slew of stocks and…

    Read more »

    Fast businessman with a car wins against the competitors.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was another day, another record high for ASX shares.

    Read more »

    Frequently Asked Questions

    No, Mesoblast does not pay shareholder dividends at this time.

    Yes, Mesoblast is listed on the ASX and the US Nasdaq under the ticker code NASDAQ: MESO.

    Mesoblast Ltd listed on the ASX on 16 December 2004.

    MSB ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Mesoblast Limited

    Mesoblast Ltd (ASX: MSB) is a clinical-stage biotechnology company. It develops and commercialises allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care.

    Its portfolio of Phase 3 product candidates includes its flagship remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD) as well as moderate to severe acute respiratory distress syndrome (ARDS). Its other candidates include REVASCOR® for advanced chronic heart failure and MPC-06-ID for chronic low back pain due to degenerative disc disease. These cell therapy candidates are towards the latter stages of their clinical trial pipelines. 

    Mesoblast has locations in Australia, the United States, and Singapore and is dual-listed on the ASX and the US Nasdaq (NASDAQ: MESO).

    Profile

    since

    Note